OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
09/19/2025
Back to search
Official data from USPTO
AMCLERUS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AMCLERUS
ST13
US500000079393086Class
5, 42, 45
Filing
79393086
Registration
7583220
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
13
Latest update
09/20/2025
Trademark type
Word
Nice classes
5, 42, 45
Filing date
02/02/2024
Registration date
12/03/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/03/2024
Last transaction
09/20/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
IE
Examiner
VERHOSEK, WILLIAM
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Prothena Biosciences Limited
Representatives
Tomkins & Co
Technical classification
Nice Classes
Class 5Class 42Class 45
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of autoimmunemetastatichematologiconcologicocular and neurologic diseasesconditions and disorders; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders associated with misfolded proteins; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of diseasesconditions and disorders affecting the central nervous system; biopharmaceuticals and pharmaceuticals for the preventiontreatmentmanagementdiagnosis and prognosis of amyloidosispsoriasispsoriatic arthritisrheumatoid arthritisdermatitishost and graft rejectionsAlzheimer's and Parkinson's-disease associated neuropsychiatric disordersinsulin resistancemetabolic syndrome and diabetes
Class 42
Research and development in the pharmaceutical and biotechnology fields
Class 45
Licensing of intellectual property in the field of biotechnology
Publications
History of USPTO decisions and trademark events.
13 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/03/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
09/03/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
01/02/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/03/2024
PUBO
PUBLISHED FOR OPPOSITION
10/01/2024
NPUB
NOTICE OF PUBLICATION
09/11/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/28/2024
DOCK
ASSIGNED TO EXAMINER
08/27/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
07/19/2024
MAFR
APPLICATION FILING RECEIPT MAILED
04/12/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/08/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/04/2024
Continuous trademark protection
Get notified about every new filing that threatens AMCLERUS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.